BAROSTIM NEO Hypertension Pivotal Trial | MicrobiomeTrials← Back to trialsNCT01679132
BAROSTIM NEO Hypertension Pivotal Trial
CompletedNAINTERVENTIONAL
Trial Details
Start: 2013-04-12Est. Completion: 2025-07
Enrollment target: 10 participants Locations- Arizona Heart Rhythm Research Center, Phoenix, Arizona, United States
- University of Southern California, Los Angeles, California, United States
- George Washington University, Washington D.C., District of Columbia, United States
- Florida Hospital, Orlando, Florida, United States
- Tampa General Hospital, Tampa, Florida, United States
- Cardiovascular Institute of the South, Houma, Louisiana, United States
- Cardiac and Vascular Research Center of Northern Michigan, Petosky, Michigan, United States
- Michigan CardioVascular Institute, Saginaw, Michigan, United States
- University Medical Center of Southern Nevada, Las Vegas, Nevada, United States
- Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
- Aspirus Wausau Hospital, Wausau, Wisconsin, United States
Other microbiome trials you might be interested in
Hypertension
This study is to evaluate the long-term safety, efficacy and tolerability of lorundrostat (an aldosterone synthase inhib…
Birmingham, United StatesEst. completion Dec 30, 2025
Uncontrolled Hypertension
The goal of this clinical trial is to learn if the drug RT-001 works to reduce high blood pressure (hypertension) in adu…
Alexander City, United StatesEst. completion Mar 2027